Skip to content

Negative Pressure Wound Therapy to Prevent Wound Complications Following Cesarean Section in High Risk Patients

Topical Negative Pressure Wound Therapy to Prevent Wound Complications Following Cesarean Section in High Risk Obstetric Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03082664
Enrollment
154
Registered
2017-03-17
Start date
2015-06-30
Completion date
2019-12-31
Last updated
2022-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Wound Disruption With Postnatal Complication, High Risk Pregnancy

Brief summary

This is a randomized controlled trial. Patients with a condition that increases their risk of a wound complication will be approached for inclusion in the trial. Each participant agreeing to study inclusion will be randomized to either suture alone or to closure of their skin incision with suture and then with prophylactic placement of a wound vac (PICO).

Detailed description

Once consent has been obtained from patients, an envelope containing the study allocation will be retrieved from the Pyxis. * Non-wound vac patients will undergo wound closure with subcutaneous fat closure with Vicryl in all cases that this is practicable (in extremely thin patients, this may not be possible), followed by subcuticular skin closure also using Vicryl. A compression dressing will then be applied. This dressing is usually removed by the clinician the following day. * Wound vac (PICO) patients will undergo wound closure with subcutaneous fat closure with Vicryl in all cases that this is practicable (in extremely thin patients, this may not be possible), followed by subcuticular skin closure also using Vicryl. The wound vac system will then be applied over the closed incision. This vac dressing will then be removed on the day of hospital discharge and replaced with a second bandage and the wound vacuum will be re-activated. The patient will remove the bandage and discard on POD#7. This is per the manufacturer's guidelines for length of use. * If the patient fails the wound vac therapy- ie the wound separates and requires traditional wound care (packing, wet to dry dressing, etc), then the PICO system is no longer used as part of their care. It would be unrealistic to try to standardize the entire operative approach (closure of the uterus, closure of the fascia) as the different providers working at the hospital may choose not to participate if the approach specified deviated too much from their usual technique. Different providers may typically use different kinds or sutures (made of different material, and of different sizes) or staples to close the subcutaneous fat and the skin. However, for this study all patients will have the subcutaneous fat and skin closed in the same manner (with Vicryl suture). To participate in the trial patients will have to agree to these closure materials. For this study a standard closure with suture was chosen as there is evidence suggesting a lower rate of wound complications with suture as compared to staples. The wound will be re-assessed at their 2 week and 6 week post-op follow up visits. The patients will be assessed by a physician at their post-operative clinic visits. The physician/investigator will ask the patient if they have had any postoperative complications since their surgery and will be asked to detail any complications if they answer yes to this question. The investigators will also obtain permission to call the participants for a patient satisfaction questionnaire at 1 week post-op, and possibly 2 and 6 weeks if they have not presented for their post op/partum appointments or the questionnaire could not be obtained at their visit.

Interventions

DEVICEPICO Single Use Negative Pressure Wound Therapy

The PICO device will be placed over the closed cesarean section incision.

Sponsors

University of Arizona
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Maternal Age 18 or above 2. Cesarean delivery 3. Maternal condition which increases the risk of wound complication. These conditions include: Obesity (BMI \>30), diabetes, HIV/AIDS, chorioamnionitis, rheumatologic disease, history of wound complication, anticoagulant therapy. 4. Patient able to read and speak English or Spanish.

Exclusion criteria

1. Minors (\<18 years of age) 2. Non-cesarean wound (ie tubal ligation wound) 3. No high risk maternal condition 4. Patient unable to read and speak English or Spanish. 5. Prisoners

Design outcomes

Primary

MeasureTime frameDescription
Wound Complicationpost operative day 1-42Number of study participants with a wound complication including wound breakdown, infection, separation or dehiscence

Countries

United States

Participant flow

Participants by arm

ArmCount
Standard Dressing
Standard dressing will be applied after C-section.
75
PICO Dressing
Device: PICO Single Use Negative Pressure Wound Therapy PICO Single Use Negative Pressure Wound Therapy: The PICO device will be placed over the closed cesarean section incision.
79
Total154

Baseline characteristics

CharacteristicPICO DressingTotalStandard Dressing
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
79 Participants154 Participants75 Participants
Age, Continuous30.5 years
STANDARD_DEVIATION 6.1
31.2 years
STANDARD_DEVIATION 6.3
31.9 years
STANDARD_DEVIATION 6.5
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants3 Participants2 Participants
Race (NIH/OMB)
Black or African American
6 Participants7 Participants1 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
8 Participants12 Participants4 Participants
Race (NIH/OMB)
White
64 Participants132 Participants68 Participants
Region of Enrollment
United States
79 participants154 participants75 participants
Sex: Female, Male
Female
79 Participants154 Participants75 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 750 / 79
other
Total, other adverse events
0 / 750 / 79
serious
Total, serious adverse events
0 / 750 / 79

Outcome results

Primary

Wound Complication

Number of study participants with a wound complication including wound breakdown, infection, separation or dehiscence

Time frame: post operative day 1-42

Population: Participants who had any follow up at either 1, 2 or 6 weeks were included.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard DressingWound Complication13 Participants
PICO DressingWound Complication14 Participants

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026